Obesity is a complex multifactorial disorder with genetic and environmental factors. There is
an increase in the worldwide prevalence of obesity in both developed and developing …

Prader-Willi syndrome is characterized by severe infantile hypotonia with poor suck and
failure to thrive; hypogonadism causing genital hypoplasia and pubertal insufficiency; …

Context: Recombinant human GH (rhGH) therapy in Prader-Willi syndrome (PWS) has been
used by the medical community and advocated by parental support groups since its …

Abstract Background: Children with Prader-Willi syndrome (PWS) have decreased muscle
mass, hypotonia, and impaired linear growth. Recombinant human GH (hGH) treatment …

Prader-Willi syndrome (PWS) is a complex genetic disorder with implications on the
endocrine and neurologic systems, metabolism, and behavior. Early in life, PWS is …

Background: The most important reason for treating children with Prader-Willi syndrome
(PWS) with GH is to optimize their body composition. Objectives: The aim of this ongoing …

Prader-Willi syndrome (PWS) is a genetic disorder characterized by short stature, low lean
body mass, muscular hypotonia, mental retardation, behavioral abnormalities, dysmorphic …

Prader-Willi syndrome (PWS) is a complex genetic disorder, caused by lack of expression of
genes on the paternally inherited chromosome 15q11. 2-q13. In infancy it is characterized …

GENETICS OF PRADER WILLI SYNDROME Chromosomal localization PWS is the most
common syndromic obesity disorder, with a prevalence of 1 in 10,000 to 1 in 15,000 live …

Prader–Willi syndrome (PWS) is a multi‐system disorder resulting from a lack of paternal
gene expression in the 15q11. 2‐q13 region. Using databases compiled through response …